Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?

F. Pitoia
  • January 2014, Bioscientifica
  • DOI: 10.1530/ERC-13-0544

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1530/ERC-13-0544

The following have contributed to this page: Fabian Pitoia